Amodiaquine as a prodrug: Importance of metabolite(s) in the antimalarial effect of amodiaquine in humans

Existing analytical methods for assaying the 4-aminoquinoline antimalarial amodiaquine in body fluids are nonspecific and obscure the fact that little or no amodiaquine is present in the blood of dosed persons. We have isolated four metabolites of amodiaquine. The two major metabolites have been ide...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Life sciences (1973) 1985-01, Vol.36 (1), p.53-62
Hauptverfasser: Churchill, Frederick C., Patchen, Leslie C., C. Campbell, Carlos, Schwartz, Ira K., Nguyen-Dinh, Phuc, Dickinson, Charlotte M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 62
container_issue 1
container_start_page 53
container_title Life sciences (1973)
container_volume 36
creator Churchill, Frederick C.
Patchen, Leslie C.
C. Campbell, Carlos
Schwartz, Ira K.
Nguyen-Dinh, Phuc
Dickinson, Charlotte M.
description Existing analytical methods for assaying the 4-aminoquinoline antimalarial amodiaquine in body fluids are nonspecific and obscure the fact that little or no amodiaquine is present in the blood of dosed persons. We have isolated four metabolites of amodiaquine. The two major metabolites have been identified; one is desethyl-amodiaquine, and the other has been tentatively identified on the basis of proton nuclear magnetic resonance spectroscopy as 2-hydroxydesethylamodiaquine. We developed a reverse-phase high-performance liquid chromatographic (HPLC) method that separates the two major metabolites from each other and from amodiaquine, allowing separate quantification. The impact of these findings on in vitro sensitivity testing and blood analysis of persons dosed with amodiaquine is discussed.
doi_str_mv 10.1016/0024-3205(85)90285-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75930897</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0024320585902851</els_id><sourcerecordid>75930897</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-dee07518b96cbd57b574028062a72cacc8fe8cbe462f4b6d20800b95f5370a0c3</originalsourceid><addsrcrecordid>eNp9kE1rFTEUhoMo9Vr9BwpZiLSL0ZPJ5GNcCKVULRS6qetwJnNiI_Nxm8wI_ffmei-XrrrK4jzvS96HsfcCPgsQ-gtA3VSyBnVm1XkLtVWVeME2wpq2Ai3FS7Y5Iq_Zm5z_AIBSRp6wE9lqZRuxYfFinPuID2uciGPmyLdp7tP6-yu_HrdzWnDyxOfAR1qwm4e40Fk-53Hiy30JTEscccAUceAUAvllx-KTzkLeryNO-S17FXDI9O7wnrJf36_uLn9WN7c_ri8vbiovrV6qngiMErZrte96ZTplmrINdI2m9ui9DWR9R42uQ9PpvgYL0LUqKGkAwctT9mnfW4Y8rJQXN8bsaRhwonnNzqhWgm1NAZs96NOcc6LgtqmsSY9OgNsZdjt9bqfPWeX-G3aixD4c-tdupP4YOigt94-HO2aPQ0jFYMxHrK0bY6Uu2Lc9RsXF30jJZR-pyO5jKhpdP8fn__EPWNiXfA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75930897</pqid></control><display><type>article</type><title>Amodiaquine as a prodrug: Importance of metabolite(s) in the antimalarial effect of amodiaquine in humans</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Churchill, Frederick C. ; Patchen, Leslie C. ; C. Campbell, Carlos ; Schwartz, Ira K. ; Nguyen-Dinh, Phuc ; Dickinson, Charlotte M.</creator><creatorcontrib>Churchill, Frederick C. ; Patchen, Leslie C. ; C. Campbell, Carlos ; Schwartz, Ira K. ; Nguyen-Dinh, Phuc ; Dickinson, Charlotte M.</creatorcontrib><description>Existing analytical methods for assaying the 4-aminoquinoline antimalarial amodiaquine in body fluids are nonspecific and obscure the fact that little or no amodiaquine is present in the blood of dosed persons. We have isolated four metabolites of amodiaquine. The two major metabolites have been identified; one is desethyl-amodiaquine, and the other has been tentatively identified on the basis of proton nuclear magnetic resonance spectroscopy as 2-hydroxydesethylamodiaquine. We developed a reverse-phase high-performance liquid chromatographic (HPLC) method that separates the two major metabolites from each other and from amodiaquine, allowing separate quantification. The impact of these findings on in vitro sensitivity testing and blood analysis of persons dosed with amodiaquine is discussed.</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/0024-3205(85)90285-1</identifier><identifier>PMID: 3965841</identifier><identifier>CODEN: LIFSAK</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Amodiaquine - metabolism ; Amodiaquine - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiparasitic agents ; Biological and medical sciences ; Biotransformation ; Chromatography, High Pressure Liquid ; Chromatography, Thin Layer ; Gas Chromatography-Mass Spectrometry ; Humans ; Magnetic Resonance Spectroscopy ; Male ; Mass Spectrometry ; Medical sciences ; Pharmacology. Drug treatments</subject><ispartof>Life sciences (1973), 1985-01, Vol.36 (1), p.53-62</ispartof><rights>1985</rights><rights>1985 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-dee07518b96cbd57b574028062a72cacc8fe8cbe462f4b6d20800b95f5370a0c3</citedby><cites>FETCH-LOGICAL-c386t-dee07518b96cbd57b574028062a72cacc8fe8cbe462f4b6d20800b95f5370a0c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0024-3205(85)90285-1$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=9247836$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3965841$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Churchill, Frederick C.</creatorcontrib><creatorcontrib>Patchen, Leslie C.</creatorcontrib><creatorcontrib>C. Campbell, Carlos</creatorcontrib><creatorcontrib>Schwartz, Ira K.</creatorcontrib><creatorcontrib>Nguyen-Dinh, Phuc</creatorcontrib><creatorcontrib>Dickinson, Charlotte M.</creatorcontrib><title>Amodiaquine as a prodrug: Importance of metabolite(s) in the antimalarial effect of amodiaquine in humans</title><title>Life sciences (1973)</title><addtitle>Life Sci</addtitle><description>Existing analytical methods for assaying the 4-aminoquinoline antimalarial amodiaquine in body fluids are nonspecific and obscure the fact that little or no amodiaquine is present in the blood of dosed persons. We have isolated four metabolites of amodiaquine. The two major metabolites have been identified; one is desethyl-amodiaquine, and the other has been tentatively identified on the basis of proton nuclear magnetic resonance spectroscopy as 2-hydroxydesethylamodiaquine. We developed a reverse-phase high-performance liquid chromatographic (HPLC) method that separates the two major metabolites from each other and from amodiaquine, allowing separate quantification. The impact of these findings on in vitro sensitivity testing and blood analysis of persons dosed with amodiaquine is discussed.</description><subject>Amodiaquine - metabolism</subject><subject>Amodiaquine - therapeutic use</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Biotransformation</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Chromatography, Thin Layer</subject><subject>Gas Chromatography-Mass Spectrometry</subject><subject>Humans</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Male</subject><subject>Mass Spectrometry</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1985</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1rFTEUhoMo9Vr9BwpZiLSL0ZPJ5GNcCKVULRS6qetwJnNiI_Nxm8wI_ffmei-XrrrK4jzvS96HsfcCPgsQ-gtA3VSyBnVm1XkLtVWVeME2wpq2Ai3FS7Y5Iq_Zm5z_AIBSRp6wE9lqZRuxYfFinPuID2uciGPmyLdp7tP6-yu_HrdzWnDyxOfAR1qwm4e40Fk-53Hiy30JTEscccAUceAUAvllx-KTzkLeryNO-S17FXDI9O7wnrJf36_uLn9WN7c_ri8vbiovrV6qngiMErZrte96ZTplmrINdI2m9ui9DWR9R42uQ9PpvgYL0LUqKGkAwctT9mnfW4Y8rJQXN8bsaRhwonnNzqhWgm1NAZs96NOcc6LgtqmsSY9OgNsZdjt9bqfPWeX-G3aixD4c-tdupP4YOigt94-HO2aPQ0jFYMxHrK0bY6Uu2Lc9RsXF30jJZR-pyO5jKhpdP8fn__EPWNiXfA</recordid><startdate>19850107</startdate><enddate>19850107</enddate><creator>Churchill, Frederick C.</creator><creator>Patchen, Leslie C.</creator><creator>C. Campbell, Carlos</creator><creator>Schwartz, Ira K.</creator><creator>Nguyen-Dinh, Phuc</creator><creator>Dickinson, Charlotte M.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19850107</creationdate><title>Amodiaquine as a prodrug: Importance of metabolite(s) in the antimalarial effect of amodiaquine in humans</title><author>Churchill, Frederick C. ; Patchen, Leslie C. ; C. Campbell, Carlos ; Schwartz, Ira K. ; Nguyen-Dinh, Phuc ; Dickinson, Charlotte M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-dee07518b96cbd57b574028062a72cacc8fe8cbe462f4b6d20800b95f5370a0c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1985</creationdate><topic>Amodiaquine - metabolism</topic><topic>Amodiaquine - therapeutic use</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Biotransformation</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Chromatography, Thin Layer</topic><topic>Gas Chromatography-Mass Spectrometry</topic><topic>Humans</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Male</topic><topic>Mass Spectrometry</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Churchill, Frederick C.</creatorcontrib><creatorcontrib>Patchen, Leslie C.</creatorcontrib><creatorcontrib>C. Campbell, Carlos</creatorcontrib><creatorcontrib>Schwartz, Ira K.</creatorcontrib><creatorcontrib>Nguyen-Dinh, Phuc</creatorcontrib><creatorcontrib>Dickinson, Charlotte M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Churchill, Frederick C.</au><au>Patchen, Leslie C.</au><au>C. Campbell, Carlos</au><au>Schwartz, Ira K.</au><au>Nguyen-Dinh, Phuc</au><au>Dickinson, Charlotte M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amodiaquine as a prodrug: Importance of metabolite(s) in the antimalarial effect of amodiaquine in humans</atitle><jtitle>Life sciences (1973)</jtitle><addtitle>Life Sci</addtitle><date>1985-01-07</date><risdate>1985</risdate><volume>36</volume><issue>1</issue><spage>53</spage><epage>62</epage><pages>53-62</pages><issn>0024-3205</issn><eissn>1879-0631</eissn><coden>LIFSAK</coden><abstract>Existing analytical methods for assaying the 4-aminoquinoline antimalarial amodiaquine in body fluids are nonspecific and obscure the fact that little or no amodiaquine is present in the blood of dosed persons. We have isolated four metabolites of amodiaquine. The two major metabolites have been identified; one is desethyl-amodiaquine, and the other has been tentatively identified on the basis of proton nuclear magnetic resonance spectroscopy as 2-hydroxydesethylamodiaquine. We developed a reverse-phase high-performance liquid chromatographic (HPLC) method that separates the two major metabolites from each other and from amodiaquine, allowing separate quantification. The impact of these findings on in vitro sensitivity testing and blood analysis of persons dosed with amodiaquine is discussed.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>3965841</pmid><doi>10.1016/0024-3205(85)90285-1</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0024-3205
ispartof Life sciences (1973), 1985-01, Vol.36 (1), p.53-62
issn 0024-3205
1879-0631
language eng
recordid cdi_proquest_miscellaneous_75930897
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Amodiaquine - metabolism
Amodiaquine - therapeutic use
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiparasitic agents
Biological and medical sciences
Biotransformation
Chromatography, High Pressure Liquid
Chromatography, Thin Layer
Gas Chromatography-Mass Spectrometry
Humans
Magnetic Resonance Spectroscopy
Male
Mass Spectrometry
Medical sciences
Pharmacology. Drug treatments
title Amodiaquine as a prodrug: Importance of metabolite(s) in the antimalarial effect of amodiaquine in humans
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T14%3A24%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amodiaquine%20as%20a%20prodrug:%20Importance%20of%20metabolite(s)%20in%20the%20antimalarial%20effect%20of%20amodiaquine%20in%20humans&rft.jtitle=Life%20sciences%20(1973)&rft.au=Churchill,%20Frederick%20C.&rft.date=1985-01-07&rft.volume=36&rft.issue=1&rft.spage=53&rft.epage=62&rft.pages=53-62&rft.issn=0024-3205&rft.eissn=1879-0631&rft.coden=LIFSAK&rft_id=info:doi/10.1016/0024-3205(85)90285-1&rft_dat=%3Cproquest_cross%3E75930897%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75930897&rft_id=info:pmid/3965841&rft_els_id=0024320585902851&rfr_iscdi=true